Anzeige
Mehr »
Login
Donnerstag, 09.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
346 Leser
Artikel bewerten:
(2)

HIV Diagnosis Market is expected to generate a revenue of USD 6.7 Billion by 2028, Globally, at 9.5% CAGR: Verified Market Research

Finanznachrichten News

An upsurge in the prevalence of HIV infection is one of the significant factors inducing growth in the demand for HIV diagnosis systems.

JERSEY CITY, N.J., Nov. 3, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "HIV Diagnosis Market" By Type (Antibody Tests, Viral Load Tests, Cd4 Tests, And Others), By Application (Diagnostic Laboratories, Hospitals, Blood Banks, And Others), and By Geography.

Verified Market Research Logo


As per the deep research carried out by Verified Market Research, the global HIV Diagnosis Market size was valued at USD 3.3 Billion in 2020 and is projected to reach USD 6.7 Billion by 2028, growing at a CAGR of 9.5% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=23957

Browse in-depth TOC on "HIV Diagnosis Market"

202 - Pages

126 - Tables

37 - Figures

Global HIV Diagnosis Market Overview

The significant factors contributing to the growth of the global HIV Diagnosis Market include the increasing prevalence of HIV worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing government initiatives. The rising preference for home access kits and tools and the increasing research and development activities in the field lead to the introduction of novel homecare technologies to diagnose HIV infection. Increasing prevalence of HIV patients worldwide, technological advancement, government initiatives, rising blood donation leading to diseases are significant factors driving the HIV Diagnosis Market during the forecast period.

Furthermore, HIV antigen, nucleic acid testing, viral load testing, and CD4 test to diagnose HIV infection is driving its market growth. In addition, many diagnosis tools are available based on both detections of HIV-specific antibodies, virus antigens, and nucleic acid. Moreover, factor driving the HIV Diagnosis Market is government and NGO's efforts to initiate against HIV. Increasing healthcare expenditure on HIV and related activities further supports the market growth. However, in the present scenario, several rapid tests are under clinical development and investigation in the product pipelines of significant market participants.

Key Players

The major players in the market are Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Thermo Fisher, Beckman Coulter, Becton & Dickinson and Company, Merck, Hologic, Bio-Rad Laboratories, and Alere.

Verified Market Research has segmented the Global HIV Diagnosis Market On the basis of Type, Application, and Geography.

  • HIV Diagnosis Market, By Type
    • Antibody Tests
    • Viral Load Tests
    • CD4 Tests
    • Others
  • HIV Diagnosis Market, By Application
    • Diagnostic Laboratories
    • Hospitals
    • Blood Banks
    • Others
  • HIV Diagnosis Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

HIV Vaccines Market By Type (Pyogenic Paronychia, Chronic Paronychia, Candidal Paronychia), By Antibiotics (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), By Geography, And Forecast

Anti-Retroviral Drugs Market By Type (Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors), By Application (HIV/AIDS, Herpes, Influenza), By Geography, And Forecast

HIV/AIDS Immunoassay Diagnostics Market By Product (Consumables, Instruments), By Test Type (Antibody Tests, Viral Load Tests, CD4 Tests), By End User (Diagnostic Laboratories, Hospitals, Blood Banks), By Geography, And Forecast

Prophylactic HIV Drug Market By Product (Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI), Integrase Inhibitor), By Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography, And Forecast

Top 10 Point-Of-Care Molecular Diagnostics Companies supplying improved testing methods

Visualize HIV Diagnosis Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/hiv-diagnosis-market-is-expected-to-generate-a-revenue-of-usd-6-7-billion-by-2028--globally-at-9-5-cagr-verified-market-research-301667527.html

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.